T2 Biosystms
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,985 | $1,952 | $2,061 | $1,679 |
Gross Profit | -2,116 | -741 | -2,141 | -895 |
EBITDA | -10,161 | -8,423 | -12,291 | |
EBIT | -10,220 | -8,485 | -12,355 | |
Net Income | -10,117 | -8,963 | -13,534 | -10,340 |
Net Change In Cash | 1,985 | 1,952 | 2,061 | 1,679 |
Free Cash Flow | -6,252 | -9,241 | -11,683 | -9,442 |
Cash | 2,083 | 4,246 | 6,208 | 15,689 |
Basic Shares | 17,892 | 14,095 | 5,094 | 4,058 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7,193 | $22,305 | $28,058 | $18,130 |
Gross Profit | -8,170 | 1,166 | 7,355 | -3,150 |
EBITDA | -43,875 | -55,196 | -41,127 | -38,487 |
EBIT | -44,734 | -57,467 | -43,665 | -41,643 |
Net Income | -50,077 | -63,370 | -53,495 | -49,208 |
Net Change In Cash | 7,193 | 22,305 | 28,058 | 18,130 |
Cost of Revenue | 6,131 | |||
Free Cash Flow | -48,328 | -50,968 | -39,334 | -44,019 |
Cash | 15,689 | 10,329 | 22,245 | 16,793 |
Basic Shares | 2,609 | 51 | 31 | 24 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.56 |
2024-06-30 | -$0.66 |
2024-03-31 | -$2.66 |
2023-12-31 | -$3.45 |
